Lipoxin A4 (LXA4) triggers selective responses with human neutrophils that are pertussis toxin sensitive and binds to high affinity receptors (Kd = 0.5 + 0.3 nM) that are modulated by stable analogues of guanosine 5'-triphosphate (GTP). Here, we characterized [11,12-3H]LXA4 specific binding with neutrophil granule and plasma membranes, which each display high affinity binding sites (Kd = 0.7 _+ 0.1 riM) that were regulated by GTP3,S. Since functional LXAa receptors are inducible in HL-60 cells, we tested orphan cDNAs encoding 7-transmembrane region receptors cloned from these cells for their ability to bind and signal with LXA4. Chinese hamster ovary (CHO) cells transfected with the orphan receptor eDNA (plNF114) displayed specific 3H-LXA4 high affinity binding (1.7 nM). When displacement of LXA4 binding with plNFl14-transfected CHO cells was tested with other eicosanoids, including LXB4, leukotriene D4 (LTD4), LTB4, or prostaglandin E2, only LTD4 competed with LXA4, giving a Ki of 80 nM. In transfected CHO cells, LXA4 also stimulated GTPase activity and provoked the release of esterified arachidonate, which proved to be pertussis toxin sensitive. These results indicate that plNF114 eDNA encodes a 7-transmembrane region-containing protein that displays high affinity for 3H-LXA4 and transmits LXA4-induced signals. Together, they suggest that the encoded protein is a candidate for a LXA4 receptor in myeloid cells.
bronchoconstrictors and are associated with the pathogenesis of asthma (1) . Lipoxins (LX) are a newer class of bioactive LO-derived products that are generated by the interactions of either 5-and 12-LO and/or 15-and 5-LO followed by subsequent reactions (for a review see reference 2). The LXs are functionally distinct from leukotrienes and other eicosanoids and are primarily generated in human tissues during cell-cell interactions that are exemplified by leukocyte-platelet interactions (2) . LXA4 displays intriguing biological re-1 Abbreuiations used in this paper: AMP-PNP, 5'-adenylylimidodiphosphate; CHO, Chinese hamster ovary cells; DPBS/PBS, Dulbecco's PBS; PBS 2-without divalent cations; FPR, formyl peptide receptor; GTPyS, guanosine 5'-O-(3-thiotriphosphate); leukotriene B4 (LTB4), 5S,12R-dihydroxy-6,14-cis-8,10-trans-dihydroxyeicosatetraenoic acid; leukotriene D4 (LTD4), 5S-
hydroxy-6R-(S-cystdnyl-glycynyl)-7,9-trans-ll,14-cis-eicosatetraenoic acid; lipoxin A4 (LXA4), 5S,6R,15S-trihydroxy-7,9,13-trans-ll-cis-eicosatetraenoic acid; lipoxin B4 (LXB4), 5S,14R,15S-trihydroxy-6,10,12-trans-8-cis-
eicosatetraenoic acid; LO, lipoxygenase; PGE2, 9-oxy-11o~,15S-dihydroxy-5-cis-13-trans-prostadienoic acid; PT, Pertussis toxin holotoxin. sponses in several tissues (2) , and with neutrophils they involve G protein-mediated signal transduction events (3) (4) (5) . A LXA4 receptor is induced in HL-60 cells upon differentiation, and it activates phospholipase D (5). LXA4-induced lipid remodeling events are similar to those of other leukocyte stimuli (i.e., LTB4 and FMLP), but specifically differ by triggering only selective responses (in the nanomolar range) without initiating aggregation or degranulation (3) . In addition, LXA4 modulates and inhibits neutrophil responses elicited by receptor-mediated stimuli including FMLP (6) (7) (8) and LTB4 in vivo (9) . Thus, LXA4 has a selective profile of action of interest in multicellular responses.
Albeit some structural similarities between LXA4 and LTB4 exist (e.g., are identical between C1-C5), LXA4 receptor interactions in neutrophils involve binding sites that are not recognized by LTB4 (3, 4) . Peptido-leukotrienes, the actions of which are antagonized by LXA4 in vivo and in vitro (10) (11) (12) , compete with 3H-LXA4 binding in neutrophils (4) . Interactions between LXA4 and LTD4 were also noted with human endothelial cells, where a putative LTD4 receptor binds 3H-LXA4 with an affinity m20-fold lower than that observed with neutrophils (5) . With the exception of endothelial and mesangial cells, where LXA4 is blocked by a LTD4 receptor antagonist (SKF104353), LXA4 specific binding is not observed with other common cell types including red cells, platelets, or lymphocytic ceU lines (5, 10) . Thus, in addition to binding with specific leukocyte LXA4 receptors, it appears that LXA4 can also interact with LTD4 receptor sites which, in certain tissues, may represent a subset or subtype of LTD4 receptors (i.e., LTD4/LXA4-r).
These results, and the finding that functional LXA4 receptors are inducible in promyelocytic lineages (HL-60 ceils) (5), as is the case for other receptors (13) (14) (15) , prompted us to investigate whether orphan 7-transmembrane receptor cDNAs recently isolated from myeloid lineages (16, 17) could encode for LXA4 receptors or binding proteins. Neutrophil Isolation and Subcellular Fractionation. Human neutrophils were obtained by the modified B6yum method (18) from fresh heparinized blood after venipuncture of healthy normal volunteers. Cell suspensions in PBS were monitored for cell number and viability. To obtain plasma membrane-and granule-enriched fractions, neutrophil fractionation was carried out as in reference 4. Briefly, after suspension in HBSS 2-containing 0.1% albumin and diisopropyl fluorophosphate (5 mM) for 30 mAn at 37~ neutrophils were adjusted to 4 x 107 cells/ml of HBSS 2-with added MgClz (2.5 mM). Next, cells kept at 4~ throughout the procedure were sonicated four times using an ice-cold probe (100 W, 15 s). Crude sonicates were supplemented with EDTA (2.5 mM final) and sequentially centrifuged at 150 (10 man), 18,000 (30 mAn), and 100,000 g (1 h). Granule-and plasma membrane-enriched fractions were recovered in the 18,000 and 100,000 g pellets, respectively, as indicated by the monitoring of marker enzymes (cf. 4).
Materials and Methods

Materials
Expression of Orphan Receptors in Chinese Hamster Ovary Cells.
Cells were grown in 100-ram pet i dishes incubated in a 5% CO2 atmosphere at 37~ in aMEM supplemented with adenosine, deoxyadenosine, and thymidine in addition to serum and antibiotics. Chinese hamster ovary (CHO) cells were transfected using the DEAE-dextran procedure (19) for transient expression of plasmid DNAs for orphan receptors (i.e., denoted pINF114, plNF154) and formyl peptide receptor (FPR) (16, 17) . The sequences of cDNA for pINF114 (17) and pINF154 (16) and deduced amino acid sequences have been reported. 48 h after transfection (10 #g DNA/dish), cells were detached using PBS 2-containing EDTA (5 raM) (3 rain, 20~ and centrifuged (200g, 10 rain) after addition of complete oeMEM (2:1 vol/vol). CHO cellpermeabilization was achieved with two cycles of freezing (dry ice-acetone bath) followed by thawing at room temperature. All cell preparations were resuspended in PBS 2+ before being used in binding assays.
Ligand Binding Assays.
[3H]LXA4 binding was performed as in (4, 5) . Briefly, centrifugation at high speed (30 s, 12,000 g) through silicon oil was used with intact cell suspensions (2-5 x 106 cell/0,5-ml aliquots), and filtration through microspin filter units (0.45 #m cellulose acetate; PGC Scientifics, Gaithersburg, MD) was used with both subcellular fractions and permeabilized cell suspensions. Incubations were performed at 4~ for the indicated duration in the presence or absence of excess unlabeled homoor hetero-ligands (1-3 log excess) to determine total and specific binding. Both pellets and filters were next resuspended in scintillation cocktail and radioactivity determined by a Wallac 1409 3-counter (Pharmacia-Wallac Oy, Turku, Finland). Results obtained were analyzed with the Ligand program (Biosoft Elsevier).
GTPase Assays. GTPase activity was determined in transfected CHO cells by a modification of the method described by Cassel and Selinger (20) . CHO cells were harvested 72 h after transfection with pINF114 or a mock vector. Adherent cells were detached from culture plates using PBS 2-(5 mM EDTA). Cells were washed with PBS and resuspended (107 cells/ml) in ice-cold buffer (containing 138 mM KC1, 25 mM Tris-HC1, I mM EGTA, 1 mM MgC12, 0.4 mg/ml creatine kinase, 5 mM phosphocreatine, 0.8 mM 5'-adenylylimAdodiphosphate [AMP-PNP], 0.1 mM ATP, 0.1 #M GTP, and 0.5 /~M [3~-32P]GTP). Cells in suspension were transferred to electroporation cuvettes kept in ice and were permeabilized with one discharge of 875 V/cm from a 250 #F capacitor (cat. no. 165-2098; Bio-Radiations, Bio-Rad Laboratories, Richmond, CA). Uptake of 32p by cells was monitored and averaged ~12% of total ['y-32P]GTP in solution. Samples were transferred to a 30~ water bath and incubated for the indicated times in the presence of agonists. Aliquots (100 #1) were removed at indicated times and added to 750 #1 of ice-cold NaH2PO4 (10 mM, pH 2.0), containing 5% (wt/vol) charcoal and 0.1% Triton X-100, and vortexed. After incubating on ice for at least 15 man, samples were centrifuged for 3 rain at 3,000 g, and radioactivity in 400 #1 of supernatant was determined by liquid scintillation counting. The rate of agonist-dependent GTPase activity was determined by subtracting the amount of free 32pi at time zero from values at designated intervals and calculating individual slopes. The rates of GTP hydrolysis in pINF114 CHO cells were equivalent to mock transfected cells with vehicle and PGE2, whereas, with LXA4, the rates in plNF114 cells were more than three times higher. Vehicle added to mock transfected CHO cells typically gave values of 0.06 pmol/min/106 cells.
Release of Estetified 3H-Arachidonate from CHO Cells. 48 h after
transfection, CHO cells were incubated for 3 h at 37~ in complete oeMEM (5 ml/dish) containing 0.1/~Ci of 3H-arachidonate/ ml. Esterification of 3H-arachidonate represented 71.0 + 12.5% of added material. Phospholipid class distribution was resolved by two-dimensional TIC (3) (with *81.1% of esterified 3H-arachidonate in the total phospholipid fractions), and the individual classes were phosphatidylserine/phosphatidylinositol, 27%; phosphatidylcholine, 24.2%; and phosphatidylethanolamine, 29.9% of the esterified label. Next, cells were washed twice and resuspended in PBS 2-(5 mM EDTA). After resuspension in PBS 2+ (2 x 106 cells/ml), cells transfected with either FPR-or plNFll4-carrying vectors were incubated at 37~ with selected putative ligand. LXA4-induced (10 -9 M) 3H-arachidonate release from plNF114 transfected CHO ceils was 2.4-11.3% of incorporated 3H-arachidonate. This was equivalent to 24.4-39.7% of the maximal release obtained using the calcium ionophore A231s7 (2.5 /zM). Background values obtained with mock and plNF114 transfected CHO
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Lipoxin A4 Receptor Is a Serpentine Receptor cells exposed to vehicle (EtOH 0.1%) were ,'~1.0% of the esterified 3H-arachidonate. In parallel determinations, cells were exposed to two commonly used phospholipase A2 inhibitors, 4-F-bromophenacyl bromide or N-(-p-amylcinnamoyl)anthranilic acid, 10 min before agonist additions. At indicated time intervals, aliquots (1 ml) were layered on a cushion of silicon and centrifuged (30 s, 12,000 g). The radiolabel content of individual superuatants (750-/~1 aliquots) was determined (21) .
Northern Blot Analysis. Multiple human tissue Northern blots (Clontech, Palo Alto, CA) containing ~2.0 /~g/lane poly(A +) RNA were probed using a plNF114 open reading frame that had been labeled with [c~-3~P]dCTP by random priming, as described (13) . Hybridization was done at 42~ for 18 h. After washing (as described in legend to Fig. 6 ), the blot was exposed to X-Omat AK5 film at -70~ overnight with an intensifying screen, after which they were stripped and reprobed with a 32p-labeled human actin (Clontech) probe using identical conditions.
Constructs. FLAG-FPR and FLAG-pINF114 were constructed employing an octapeptide (DYKDDDDK) encoding sequence termed FLAG as in (22) . All constructs were inserted into the EcoRI site of pRc/CMV that had been mutated so as to have a single EcoRI site located within the cloning site (22) .
Results
Specific binding of [11,12-3H] LXA4 in human neutrophils gives a Ka of 0.5 + 0.3 nM and is distributed in plasma membrane-(~42%), granule-(34.5%), and nuclear-(23.3%) enriched fractions. 3H-LXA4 binding with intact neutrophils and plasma membrane is modulated by GTP stable analogs (4) . To determine whether the interaction of 3H-LXA4 with different subcellular fractions gives similar characteristics, [11,12-3H ]LXA4 specific binding with granule membrane was compared with that observed with plasma membrane-enriched fractions. Isothermic binding was performed at 4~ with ~H-LXA4 (0.1-15 nM) in the presence or absence of a 3 log excess of unlabeled LXA4. Results from Scatchard analyses show that 3H-LXA4 binds neutrophil granule membrane-enriched fractions with comparable Ka (0.8 nM) but larger B~, (4.1 x 10 -11 M) than with plasma membranes (Ka 0.7 riM, Bm~, 2.1 x 10-11 M) (Fig. 1) . In addition, exposure of granule membrane fractions to GTPqrS, a stable analog of GTP, reduced the Bmax (2.7 x 10 -11 M) to values similar to those observed for 3H-LXA4 specific binding with plasma membranes (Fig. 1) . These findings suggest that 3H-LXA4 binding to intact neutrophils and granule membrane-associated fractions involves one class of binding sites. Therefore, a higher abundance of LXA4 receptors is likely for total cellular copies than that calculated solely on the basis of cell surface receptor expression (~1,800/ cell in neutrophils, cf. 4). This granule membrane-associated fraction of LXA4 binding sites may represent a reserve store as documented for other neutrophil receptors (23) .
Since LXA4 specific and functional receptors present in neutrophils are induced upon differentiation in HL-60 cells receptor (16, 17) . High affinity ligands have not been identified for these sequence-related putative receptors, and they were coined FMLP homologous orphan receptors (16) or related FMLP receptors (RFP; 17). CHO cells were transfected with these cDNAs and tested for their ability to bind [11,12-3H] LXA4 (48 h after transfection). As shown in Fig. 2 (le~) , CHO cells transfected with plNF114 display specific binding with LXA4 (Ka ~5 nM), and, for purposes of direct comparison, those transfected with FPR (right) displayed high affinity binding for its ligand FMLP (Kd ~5 nM). Nonspecific binding was comparable with both ligands (Fig. 2) . 3H-LXA4 did not display high affinity binding with several other related orphan 7 transmembrane region receptors transfected in CHO cells including plNF154 (see 16, 17) (data not shown). Albeit a low abundance of ~2,000 LXA4 receptors per cell was observed with intact cells (Fig. 2) x <, so ~ 30007
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,ot,c, 10 -1~ x 10 -11M for FMLP and 3.6 x 10 -1~ versus 5.2 x 10-11 M for LXA4) (see Fig. 2, bottom) . Next, pINF114 cDNA was modified at the corresponding NH2-terminus sequence to contain a FLAG peptide-encoding sequence (22) . After transfection, FLAG-plNF114-expressing cells were harvested (48 h) and fractionated, and individual enriched fractions for nuclei, organdie, and plasma membrane were electrophoresed by polyacrylamide gel. Western blot analysis with a mouse mAb recognizing the FLAG peptide portion showed the distribution of plNF114 construct associated with plasma membranes as "~35%, organelle pellet "~52%, and nuclei '~13%. Given the higher Bm~ obtained with permeabilized cell suspensions and the finding that >50% ofplNFll4-encoded protein was associated with intracellular fractions, permeabilized transfected CHO cells were used to further charac- x 107 cells/ml. Aliquots (200 #1) were added to microcentrifuge tubes containing 800 #1 of PBS 2+ and 3H-LXA4 (0.3 nM final) alone, or in the presence of increasing concentrations of indicated compounds (3-300 nM). All solutions were kept at 4~ Cells were incubated for 5 rain followed by layering aliquots (0. terize 3H-LXA4 binding to the plNF114 product. Time course of label association at 4~ gave results similar to those obtained with neutrophils, and equilibrium binding was obtained within 5 min (data not shown). Analysis ofisothermic binding of 3H-LXA4 (1-15 nM, 5 min at 4~ to plNF114 transfected CHO cells gave a Ka of 1.7 +_ 0.8 nM and a Bmax of 3.8 -+ 0.5 x 10 -1~ M (Fig. 3) . These values are in agreement with the Ka values obtained for both neutrophil and retinoic acid differentiated HL-60 cells (5).
LXA4 binding with neutrophils and HL-60 cells is stereoselective in that neither LTB4 nor LXB4 competes for LXA4 binding (4) . Structural requirements for 3H-LXA4 binding with plNF114-transfected CHO cells were examined with LXB4, LTD4, LTB4, or PGE2. Only LTD4 proved effective in displacing tritiated LXA4 binding with plNF114 transfected CHO cells (Ki ~80 nM, Table 1 ). Results are consistent with those obtained with neutrophils (4, 5) where, among the compounds examined, only LTD4 competed with 3H-LXA4 binding (Ki ~70 riM). These findings indicated that specific LXA4 binding with plNF114-transfected CHO cells is selective, prompting the assessment oftransmembrane signaling.
Does plNF114 Transduce LXA4 Signals? As shown in Fig.   4 , after transfection of CHO cells with plNF114, LXA4 specifically induced GTPase activity. The maximum rate triggered by LXA4 was reached within 30 s and proved to be concentration dependent (data not shown). LXB4 and PGE2 gave significantly lower levels of GTPase activity than LXA4. LTD4 also stimulated GTPase activity in plNF114 transfectants when activity associated with mock transfectants assayed in parallel was subtracted (Fig. 4, inset) . These results suggest that the structure--function relationship for stimulating GTPase activity is similar to that obtained for 3H-LXA4 binding competition (Table 1) .
LXA4 stimulates arachidonate release (2, 3) , and CHO cells can mobilize arachidonate in response to ligand-specific stimulation of transfected receptors (21) . Next, plNFl14-CHO and mock transfected CHO cells were labeled with 3H-arachidonate and exposed to LXA4 (10 -9 M) to determine whether this receptor can stimulate release. A specific, LXA4-dependent release of esterified 3H-arachidonic acid was obtained with pINF114 transfected CHO cells (Fig. 5) . Time course experiments showed maximal release in the 3-5 min interval with a subsequent decline. A similar profile was also observed for FMLP-induced release of esterified 3H-arachidonic acid with FPR transfected CHO cells, reported for purposes of direct comparison ( Fig. 5 and its inset) . Both LXA4-(10-9 M) and FMLP (10-7 M)-induced arachidonate release proved sensitive to phospholipase inhibitors N-(-p-amylcinnamoyl)anthranilic acid (100 #M) (n = 3) and 4-p-bromophenacyl bromide (n = 1; 50/~M) (data not shown). Selective inhibition of LXA4-induced release of 3H-arachidonate from plNF114 transfected CHO cells was observed when labeled cells were exposed to PT (4-6 h, 37~ before agonist addition (Table 2 ). To ensure that PT treatment did not simply impact in the agonist's temporal response, time course of 3H-arachidonate release was monitored at 0-, 5-, and 10-min intervals (data not shown). Thus, CHO cells transfected with plNF114 specifically bind and give responses with LXA4.
Preliminary studies on the distribution of mRNA for this receptor showed that the most abundant levels for the spe- After 3H-arachidonate labeling (37~ 3 h), cells were exposed to increasing concentrations (0-10-100 ng/ml) of PT (37~ 6 h). At 5 rain after additions, 3H-arachidonate release was measured as described in the legend to des of interest (i.e., •1.8-2.0 kb) were associated with human lung, followed by placenta (Fig. 6) , tissues known to have a relatively high degree of phagocytic cell infiltrates. Other bands were observed that crosshybridize with this receptor (Fig. 6) . The present results establish that the interactions of LXA4 with cells expressing plNFll4, a previously isolated orphan receptor of the 7-transmembrane region class (16, 17) , meet the criteria commensurate with ligand-receptor interactions and transmembrane signaling (25) . Namely, transfected cells display specific binding with 3H-LXA4 that is displaced with excess unlabeled ligand (Fig. 2) . Binding was selective for LXA4 in that other eicosanoids including LXB4, LTB4, and PGE2 did not displace LXA4 specific binding (Table 1) . CHO cells possess the components required for transmembrane signaling with activation of phospholipases after expressing rogue 7-transmembrane spanning receptors and addition of appropriate ligands (21, 26) . In the present experiments, CHO cells transfected with plNFll4 transduced signal in response to LXA4, by both activating GTPase (Fig.  4) and releasing arachidonic acid (Fig. 5) . Thus, the product encoded by plNFll4 specifically binds 3H-LXA4 and transduces signals with LXA4, indicating that plNFll4 is a candidate for a functional LXA4 receptor. This does not, however, preclude the existence of other LXA4 binding sites or other receptors in addition to the product of plNF114 that can transduce LXA4 signals. To date, neither LTD4 receptors nor other receptors for LO-derived products have been cloned. LTD4 did displace 3H-LXA4 from transfected CHO cells (Ki, 79.9 nM) and gave '~65-70% of the GTPase activity when compared with equimolar amounts of LXA4 (inset, Fig. 3 ). LTD4 competes for 3H-LXA4 binding (5) , and, in certain tissues, LXA4 and peptido-leukotrienes appear to share a common site of action (5, (10) (11) (12) . Thus, the present findings suggest that certain types or subclasses of peptidoleukotriene receptors may be structurally related to the plNF114 encoded receptor.
plNF114 and plNF154 were originally sequenced as FMLPrelated receptors and coined "related formyl peptide receptors" (RFP) (16, 17) . FPR transduces signal with FMLP (22) , and FMLP clearly activates leukocytes; however, the endogenous ligands for these receptors have been questioned earlier (23) . FMLP is a synthetic analogue and is thought to be a surrogate of N-formylated, bacterial-derived proteins (23) . An endogenous extraceUular ligand for the FMLP receptor is not established. Although Carp (27) noted that N-formyl methionyl proteins from mitochondria of damaged cells are chemoattractant for PMN and that this response is blocked with a FMLP receptor antagonist, it still remains unclear as to whether N-formylated proteins are unique ligands for the class of receptors (23) . The present results indicate that at least one FPR receptor-related sequence is a receptor for a lipid-derived ligand. In this regard, it is of interest that the plNF114 gene has been mapped to chromosome 19, as have the genes for the complement component 5a receptor (16) and the recently identified thromboxane A2 receptor gene (28) . The present results will now permit further analysis of LX site(s) of action, the mechanism underlying LXA4 responses such as inhibition of neutrophil function (6) (7) (8) (9) , and elucidation of components involved in LX signal transduction.
